BCL2 and hematopoietic and lymphoid system neoplasm: Overexpression of anti-apoptotic BCL2 family proteins resulting from chromosomal translocation, gene amplification, increased gene transcription, or alteration of post-transcriptional processing has been found for many solid and hematologic neoplasms [22,23].